Free masterclass to arm veterinarians with regenerative medicine knowledge

File image.

The Celtic Advanced Life Science Innovation Network (CALIN) team, based at the Regenerative Medicine Institute (REMEDI) of the University of Galway (Ireland) is hosting a free virtual series on veterinary regenerative medicine.

This Masterclass gives an overview of the knowledge and skills needed for the next generation of veterinary surgeons interested in introducing regenerative therapeutic solutions in their clinical practice.

The veterinary clinical landscape is changing as regenerative technologies offer innovative solutions for age-related degenerative conditions in animals. Education, skills and know-how are needed to successfully incorporate regenerative therapies. These include being familiar with the latest terminology, technologies, clinical application and mechanisms of action behind the potential to restore the form and function of diseased cells, tissues and organs.

Proficiency in these concepts and their correct implementation will transform the current standard of care procedures in veterinary medicine leading potentially to improved therapeutic outcomes and a reduced number of adverse effects in animal patients.

Certificates of attendance for CPD purposes will be issued to all of the attendees. Additionally, veterinary surgeons registered with the Veterinary Council of Ireland will receive 1CVE, and certificates will be issued containing QR codes for 1CPD for colleagues registered with the Royal College of Veterinary Surgeons.

The first four webinars have been recorded and are available to be viewed, with the final two scheduled for December 6 and December 22.

Webinar 1: One Health and Regenerative Medicine
Prof Frank Barry, University of Galway and Colorado State University
learning outcomes:
• To acquire trans-disciplinary knowledge and thinking for the correct application of cell therapies in the clinical setting
• To describe the benefits and potential of interdisciplinary collaborations under the One Health umbrella
• To recognize the current challenges for translation application of cell therapies for the treatment of osteoarthritis.

Webinar 2: Cell Therapies for Wildlife & Exotic Animals
Professor Valerie Johnson, Michigan State University
learning outcomes:
• Sources of Mesenchymal Stromal Cells in exotic species and wildlife
• Current clinical evidence of treatment with MSCS in exotic species and wildlife
• Clinical management indications on regenerative therapies in the exotic animal medicine practice.

Webinar 3: Mesenchymal Stromal Cell Therapies for Osteoarthritis
Dr Ana Ivanovska, University of Galway
learning outcomes:
• To describe the biology and therapeutic mechanism of action of MSCs
• To gain an understanding of clinical applications of MSCs in animal patients
• To recognize and implement the current evidence on the use of MSCs in animal patients

This Masterclass will give an overview of the knowledge and skills needed for the next generation of veterinary surgeons interested in introducing regenerative therapeutic solutions in their clinical practice.

Webinar 4: Cell Therapies for Bacterial Infections
Prof. Steven Dow, Colorado State University
learning outcomes:
• Antimicrobial properties and mechanisms of action of Mesenchymal Stromal Cells (MSCS)
• Clinical evidence of animals with spontaneous drug-resistant bacterial infections treated with MSCS
• Clinical management of drug-resistant infections with MSCS.

Webinar 5: Animal-Induced Pluripotent Stem Cells
Dr Laura Barrachina, University of Galway
learning outcomes:
• Understand the definition, basic characteristics of iPSCs and the state of the art in iPSCs in veterinary medicine
• Be aware of the limitations with particular emphasis on the challenges posed by veterinary species
• Realize the importance of the joint advancement of human and veterinary medicine in the iPSCs field.
» Register for the webinar on December 6

Webinar 6: Animal Cell-Free Therapies
Dr Tarlan Eslami Arshaghi, University of Galway
learning outcomes:
• Defining the different cell-free therapy and their sources with a stringent focus on EVs
• Understanding the biology of the cell secretion factors and addressing their mechanisms of action
• Discussing the possible pathway of a cell-free product from bench to manufacturing state
» Register for the webinar on December 13